Clinical Trials Browser

Phase 1/2 × Prostatic Neoplasms × Vinorelbine × Clear all

NCT00151086 2015-01-22

Oral Estramustine and Oral Vinorelbine in the Treatment of Hormone-Refractory Prostate Cancer

Phase 1/2 Completed

Prostatic Neoplasms